Global Viral Vectors Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Retroviral Vectors), Disease (Cancers, Genetic Disorders, Infectious Diseases), Application, End User - Forecast 2024-2030- Product Image

Sale

Global Viral Vectors Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Retroviral Vectors), Disease (Cancers, Genetic Disorders, Infectious Diseases), Application, End User - Forecast 2024-2030

Report
191 Pages
March 2024
Region: Global
360iResearch™
ID: 5666371

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Viral Vectors Market size was estimated at USD 1.66 billion in 2023, USD 1.88 billion in 2024, and is expected to grow at a CAGR of 14.09% to reach USD 4.18 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viral Vectors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viral Vectors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viral Vectors Market, highlighting leading vendors and their innovative profiles. These include ABL Inc., Batavia Biosciences B.V., Bio-Rad Laboratories, Inc., BioNTech IMFS GmbH, Biovian Oy, Cevec Pharmaceuticals GmbH, Creative Biogene, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., GeneOne Life Science, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Sirion-Biotech GmbH, Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Viral Vectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Adeno-associated Viral Vectors
- Adenoviral Vectors
- Retroviral Vectors
Disease
- Cancers
- Genetic Disorders
- Infectious Diseases
Application
- Gene Therapy
- Vaccinology
End User
- Pharmaceutical & Biopharmaceutical Companies
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Viral Vectors Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viral Vectors Market?
What are the technology trends and regulatory frameworks in the Viral Vectors Market?
What is the market share of the leading vendors in the Viral Vectors Market?
Which modes and strategic moves are suitable for entering the Viral Vectors Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Viral Vectors Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing vaccine production for various infections and viruses
5.1.1.2. Growing prevalence of target ailments and diseases
5.1.1.3. Government initiatives for cell and gene therapy treatments
5.1.2. Restraints
5.1.2.1. High cost of gene & cell therapy treatments
5.1.3. Opportunities
5.1.3.1. Ongoing research and development in rare disease treatments
5.1.3.2. Investments by large contract development and manufacturing organizations
5.1.4. Challenges
5.1.4.1. Risk of insertional mutagenesis and immune response
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Viral Vectors Market, by Type

6.1. Introduction
6.2. Adeno-associated Viral Vectors
6.3. Adenoviral Vectors
6.4. Retroviral Vectors

7. Viral Vectors Market, by Disease

7.1. Introduction
7.2. Cancers
7.3. Genetic Disorders
7.4. Infectious Diseases

8. Viral Vectors Market, by Application

8.1. Introduction
8.2. Gene Therapy
8.3. Vaccinology

9. Viral Vectors Market, by End User

9.1. Introduction
9.2. Pharmaceutical & Biopharmaceutical Companies
9.3. Research Institutes

10. Americas Viral Vectors Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Viral Vectors Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Viral Vectors Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. ABL Inc.
14.1.2. Batavia Biosciences B.V.
14.1.3. Bio-Rad Laboratories, Inc.
14.1.4. BioNTech IMFS GmbH
14.1.5. Biovian Oy
14.1.6. Cevec Pharmaceuticals GmbH
14.1.7. Creative Biogene
14.1.8. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
14.1.9. GeneOne Life Science, Inc.
14.1.10. Lonza Group Ltd.
14.1.11. Merck KGaA
14.1.12. Miltenyi Biotec B.V. & Co. KG
14.1.13. Sirion-Biotech GmbH
14.1.14. Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
14.1.15. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. VIRAL VECTORS MARKET RESEARCH PROCESS
FIGURE 2. VIRAL VECTORS MARKET SIZE, 2023 VS 2030
FIGURE 3. VIRAL VECTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VIRAL VECTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VIRAL VECTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VIRAL VECTORS MARKET DYNAMICS
FIGURE 7. VIRAL VECTORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. VIRAL VECTORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VIRAL VECTORS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. VIRAL VECTORS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VIRAL VECTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VIRAL VECTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VIRAL VECTORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VIRAL VECTORS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. VIRAL VECTORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VIRAL VECTORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. VIRAL VECTORS MARKET SIZE, BY ADENO-ASSOCIATED VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VIRAL VECTORS MARKET SIZE, BY ADENOVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VIRAL VECTORS MARKET SIZE, BY RETROVIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 10. VIRAL VECTORS MARKET SIZE, BY CANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VIRAL VECTORS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. VIRAL VECTORS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. VIRAL VECTORS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. VIRAL VECTORS MARKET SIZE, BY VACCINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. VIRAL VECTORS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. VIRAL VECTORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 34. CANADA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES VIRAL VECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 56. CHINA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 60. INDIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 129. ITALY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. POLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 149. QATAR VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM VIRAL VECTORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. VIRAL VECTORS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. VIRAL VECTORS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. VIRAL VECTORS MARKET LICENSE & PRICING

Companies Mentioned

ABL Inc.
Batavia Biosciences B.V.
Bio-Rad Laboratories, Inc.
BioNTech IMFS GmbH
Biovian Oy
Cevec Pharmaceuticals GmbH
Creative Biogene
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
GeneOne Life Science, Inc.
Lonza Group Ltd.
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
Sirion-Biotech GmbH
Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	191
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.88 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.18 Billion
Compound Annual Growth Rate	14.0%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Forecast 2024-2030

Viral Vector Market Size, Share & Trends Analysis Report By Vector Type (Adeno-associated Virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Global Viral Vector and Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Vector Type (AAV, Lentivirus), Workflow, Application, End-use, Disease, Region, and Segment Forecasts, 2024-2030

Global Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Forecast 2023-2030

Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028

About the Viral Vector Market